SIR Issues a Statement of Commitment in Support of Diversity

“We Believe in Diversity and Inclusion”

June 3, 2020

SIR (Society of Interventional Radiology) President Michael D. Dake, MD, FSIR, and Diversity and Inclusiveness Group Chair Paul J. Rochon, MD, FSIR, issued the following statement on supporting diversity and combating racial inequality in America.

Humanity has been dealt with many challenges this year. While COVID-19 has undoubtedly received much of our attention, we suffer from another pandemic that remains a structural and pernicious threat—racism. The Society of Interventional Radiology (SIR) will not be silent on this issue.

We denounce any act of hatred and bigotry on the basis of race, ethnicity, religion, sexual orientation, or gender identity. We denounce the long history of hatred and violence against the Black community and support our Black patients, physicians, trainees, nurses, technologists, industry partners, staff, and administrators. We need to stand together in strength and work with a common purpose to realize a more diverse, equitable, and inclusive organization.

We commit to antiracist efforts, policies, and programs that aim to increase the numbers of underrepresented minorities and women within our specialty. Our GEMS program supports diversity in interventional radiology by providing a travel grant for medical students from diverse backgrounds who desire to participate in a visiting clerkship in interventional radiology (IR) outside of their home institution.

We value a culture of inclusion in which all members of the IR community are accepted, respected, and embraced. The society’s IAmIR campaign has both celebrated and drawn attention to diversity within the specialty. SIR has microgrants that support research performed by female and underrepresented minority scientists and a speakers’ bureau to ensure IRs of color are tapped as experts in their field at scientific meetings.

We strongly support the need to reduce and eliminate health disparities that affect our Black patients and other patients of color. SIR’s Diversity and Inclusiveness Group Task Force has been working for several years to ensure that these issues are a vital part of our strategic plan.

We call upon our membership and affiliates to take this time to remember the families and communities of George Floyd, Breonna Taylor, Ahmaud Arbery, and many others who have been subject to unconscionable acts of discrimination and hate. We ask that everyone look into his or her heart to understand the overdue need for change in the nation. With our intentional efforts, SIR calls to action the continuing need to develop strategies to ensure justice, diversity, equity, and inclusion.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version